Clinical Trial Update: A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase II trial evaluating intranasal GSK256066 in combination with azelastine hydrochloride for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• AZELASTINE HYDROCHLORIDE (azelastine hydrochloride)
• GSK256066

Snippet

Sponsor: GlaxoSmithKline | Conditions: Allergic Rhinitis, Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED